*** Welcome to piglix ***

Ketanserin

Ketanserin
Ketanserin.png
Clinical data
Trade names Sufrexal
AHFS/Drugs.com International Drug Names
ATC code C02KD01 (WHO) QD03AX90 (WHO)
Identifiers
Synonyms R41468; R-41468; R-41,468
CAS Number 74050-98-9 YesY
PubChem (CID) 3822
IUPHAR/BPS 88
ChemSpider 3690 YesY
UNII 97F9DE4CT4 YesY
KEGG D02363 YesY
ChEBI CHEBI:6123 N
ChEMBL CHEMBL51 YesY
ECHA InfoCard 100.070.598
Chemical and physical data
Formula C22H22FN3O3
Molar mass 395.43 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  

Ketanserin (INN, USAN, BAN) (brand name Sufrexal; former developmental code name R41468) is a drug used clinically as an antihypertensive agent and in scientific research to study the serotonin system; specifically, the 5-HT2 receptor family. It was discovered at Janssen Pharmaceutica in 1980.

Ketanserin is classified as an antihypertensive by the World Health Organization and the National Institute of Health.

It has been used to reverse pulmonary hypertension caused by protamine (which in turn was administered to reverse the effects of heparin overdose).

The reduction in hypertension is not associated with reflex tachycardia.

It has been used in cardiac surgery.

With tritium (3H) radioactively labeled ketanserin is used as a radioligand for serotonin 5-HT2 receptors, e.g. in receptor binding assays and autoradiography. This radio-labeling has enabled the study of serotonin 5-HT2A receptor distribution in the human brain.

An autoradiography study of the human cerebellum has found an increasing binding of 3H-ketanserin with age (from below 50 femtomol per milligram tissue at around 30 years og age to over 100 above 75 years). The same research team found no significant correlation with age in their homogenate binding study.


...
Wikipedia

...